Amgen Inc. buy Royal Bank of Canada
Start price
07.04.26
/
50%
€292.40
Target price
07.04.27
€320.90
Performance (%)
2.54%
Price
17.06.26
€297.30
Summary
This prediction is currently active. With a performance of 2.54%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 07.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 1.589% | 1.589% |
| iShares Core DAX® | 2,90 % | 3,65 % |
| iShares Nasdaq 100 | 4,60 % | 3,06 % |
| iShares Nikkei 225® | 10,42 % | 12,61 % |
| iShares S&P 500 | 2,57 % | 1,36 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $360.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat